DK1482967T3 - Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1 - Google Patents

Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1

Info

Publication number: DK1482967T3
Authority: DK; Denmark
Prior art keywords: plgf; pharmaceutical; cosmetic compositions; comprehensive; compositions comprehensive
Prior art date: 2002-03-05

Application number

DK03712652.1T

Other languages

English (en)

Inventor

Domenico Maglione

Mauro Battisti

Ettore Conti

Giuseppe Salvia

Marina Tucci

Original Assignee

Geymonat Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-05

Filing date

2003-03-05

Publication date

2013-08-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1482967(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-05 Application filed by Geymonat Spa filed Critical Geymonat Spa

2013-08-26 Application granted granted Critical

2013-08-26 Publication of DK1482967T3 publication Critical patent/DK1482967T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Zoology (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Physical Education & Sports Medicine (AREA)
Gerontology & Geriatric Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Birds (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK03712652.1T 2002-03-05 2003-03-05 Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1 DK1482967T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2002RM000119A ITRM20020119A1 (it)	2002-03-05	2002-03-05	Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
PCT/IT2003/000132 WO2003074075A1 (en)	2002-03-05	2003-03-05	Pharmaceutical and cosmetic compositions comprising plgf-1

Publications (1)

Publication Number	Publication Date
DK1482967T3 true DK1482967T3 (da)	2013-08-26

Family

ID=11456138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03712652.1T DK1482967T3 (da)	2002-03-05	2003-03-05	Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1

Country Status (20)

Country	Link
US (1)	US7364722B2 (da)
EP (1)	EP1482967B1 (da)
JP (2)	JP5010093B2 (da)
KR (1)	KR100988656B1 (da)
CN (1)	CN100467058C (da)
AU (1)	AU2003217464B2 (da)
BR (1)	BR0308040A (da)
CA (1)	CA2477075C (da)
CY (1)	CY1114209T1 (da)
DK (1)	DK1482967T3 (da)
ES (1)	ES2424827T3 (da)
HR (1)	HRP20040914A2 (da)
IT (1)	ITRM20020119A1 (da)
MX (1)	MXPA04008486A (da)
PL (1)	PL371788A1 (da)
PT (1)	PT1482967E (da)
RU (1)	RU2292906C2 (da)
SI (1)	SI1482967T1 (da)
WO (1)	WO2003074075A1 (da)
ZA (1)	ZA200407707B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2872040B1 (fr) *	2004-06-23	2006-09-22	Centre Nat Rech Scient Cnrse	Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) *	2006-10-30	2011-11-15	Warsaw Orthopedic, Inc.	Method for treating facet pain
EP2394666A2 (en) *	2009-02-05	2011-12-14	Digna Biotech, S.L.	Pharmaceutical compositions comprising tgf- beta 1 inhibitor peptides
US8741850B2 (en)	2009-07-24	2014-06-03	Advanced Accelerator Applications S.A.	Compounds modulators of VEGF activity and uses thereof
WO2014117155A1 (en) *	2013-01-28	2014-07-31	Shire Human Genetic Therapies, Inc.	Placenta growth factor in treating duchenne muscular dystrophy
WO2015109329A1 (en)	2014-01-17	2015-07-23	Mimedx Group, Inc.	Method for inducing angiogenesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1283892A (en) *	1970-06-08	1972-08-02	Irwin Irville Lubowe	Improvements in and relating to medicinal compositions for application to the skin and/or hair
IT1242149B (it) *	1990-09-27	1994-02-16	Consiglio Nazionale Ricerche	Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
CA2229479C (en) *	1995-08-15	2010-03-30	Connective Therapeutics, Inc.	Method of promoting angiogenesis
RU2102091C1 (ru) *	1995-09-19	1998-01-20	Казанский медицинский университет	Способ лечения системной склеродермии
AU7003096A (en) *	1996-06-21	1998-01-07	Jury Evgenievich Belyaev	Semi-finished product for producing drug bases, bases obtained using the same and variants, and drugs obtained using these bases and variants
CA2315977A1 (en) *	1997-12-24	1999-07-08	Ludwig Institute For Cancer Research	Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
CA2377435A1 (en) *	1999-06-29	2001-01-04	J. Alexander Marchosky	Compositions and methods for forming and strengthening bone
JP3877914B2 (ja) *	1999-09-07	2007-02-07	サンスター株式会社	皮膚化粧料
WO2001057181A2 (en) *	2000-02-04	2001-08-09	Carmeliet, Peter	Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2001316242A (ja) *	2000-03-02	2001-11-13	Noevir Co Ltd	皮膚外用剤
EP1267800A4 (en) *	2000-03-31	2004-08-25	Gen Hospital Corp	METHOD FOR INFLUENCING HAIR GROWTH

2002
- 2002-03-05 IT IT2002RM000119A patent/ITRM20020119A1/it unknown
2003
- 2003-03-05 JP JP2003572591A patent/JP5010093B2/ja not_active Expired - Fee Related
- 2003-03-05 BR BR0308040-4A patent/BR0308040A/pt active Search and Examination
- 2003-03-05 PT PT37126521T patent/PT1482967E/pt unknown
- 2003-03-05 EP EP03712652.1A patent/EP1482967B1/en not_active Expired - Lifetime
- 2003-03-05 DK DK03712652.1T patent/DK1482967T3/da active
- 2003-03-05 ES ES03712652T patent/ES2424827T3/es not_active Expired - Lifetime
- 2003-03-05 PL PL03371788A patent/PL371788A1/xx unknown
- 2003-03-05 RU RU2004129586/15A patent/RU2292906C2/ru not_active IP Right Cessation
- 2003-03-05 CN CNB038051532A patent/CN100467058C/zh not_active Expired - Fee Related
- 2003-03-05 WO PCT/IT2003/000132 patent/WO2003074075A1/en not_active Ceased
- 2003-03-05 US US10/507,272 patent/US7364722B2/en not_active Expired - Fee Related
- 2003-03-05 SI SI200332290T patent/SI1482967T1/sl unknown
- 2003-03-05 AU AU2003217464A patent/AU2003217464B2/en not_active Ceased
- 2003-03-05 HR HRP20040914 patent/HRP20040914A2/hr not_active Application Discontinuation
- 2003-03-05 CA CA2477075A patent/CA2477075C/en not_active Expired - Fee Related
- 2003-03-05 KR KR1020047013804A patent/KR100988656B1/ko not_active Expired - Fee Related
- 2003-03-05 MX MXPA04008486A patent/MXPA04008486A/es active IP Right Grant
2004
- 2004-09-23 ZA ZA2004/07707A patent/ZA200407707B/en unknown
2010
- 2010-01-18 JP JP2010007759A patent/JP5144690B2/ja not_active Expired - Fee Related
2013
- 2013-08-13 CY CY20131100692T patent/CY1114209T1/el unknown

Also Published As

Publication number	Publication date
JP2005519101A (ja)	2005-06-30
JP2010116405A (ja)	2010-05-27
AU2003217464A1 (en)	2003-09-16
HK1078469A1 (zh)	2006-03-17
PL371788A1 (en)	2005-06-27
RU2292906C2 (ru)	2007-02-10
ITRM20020119A1 (it)	2003-09-05
US7364722B2 (en)	2008-04-29
CN1638793A (zh)	2005-07-13
CY1114209T1 (el)	2016-08-31
KR20040111379A (ko)	2004-12-31
ES2424827T3 (es)	2013-10-08
EP1482967B1 (en)	2013-05-15
BR0308040A (pt)	2004-12-14
AU2003217464B2 (en)	2007-08-30
US20050239698A2 (en)	2005-10-27
CA2477075A1 (en)	2003-09-12
HRP20040914A2 (en)	2004-12-31
SI1482967T1 (sl)	2013-10-30
ITRM20020119A0 (it)	2002-03-05
US20050075288A1 (en)	2005-04-07
JP5144690B2 (ja)	2013-02-13
EP1482967A1 (en)	2004-12-08
CA2477075C (en)	2013-08-06
WO2003074075A1 (en)	2003-09-12
MXPA04008486A (es)	2005-04-19
CN100467058C (zh)	2009-03-11
JP5010093B2 (ja)	2012-08-29
ZA200407707B (en)	2005-07-27
KR100988656B1 (ko)	2010-10-18
PT1482967E (pt)	2013-08-27
RU2004129586A (ru)	2005-06-10

Publication	Publication Date	Title
IS7948A (is)	2005-07-20	Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
DK1713544T3 (da)	2009-11-16	Sammensætninger og fremgangsmåder til oral og personlig pleje
DE60317699D1 (de)	2008-01-03	Fermentationsverfahren und -zusammensetzungen
FR2842417B1 (fr)	2005-01-21	Composition cosmetique
FR2842416B1 (fr)	2004-12-17	Composition cosmetique
KR20050009999A (ko)	2005-01-26	약제학적 제제
IS3007B (is)	2018-12-15	Ónæmisbælandi efnasambönd og efnablöndur
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20052524D0 (no)	2005-05-26	Aminerte isofiavonoidderivater og anvendelse derav
IL173726A (en)	2013-06-27	Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
DK1354873T3 (da)	2004-11-01	Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
PT1558595E (pt)	2010-01-15	Piperazinil e diazepanil benzamidas e benzotioamidas
IL163868A (en)	2011-11-30	Hemiasterlin derivatives and pharmaceutical compositions comprising them
EP1565205A4 (en)	2006-07-05	Interferon-alpha polypeptides and conjugates
DK1663291T3 (da)	2012-07-02	Rekombinante lubricinmolekyler og anvendelser deraf
IL170313A (en)	2010-11-30	Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
GB0212749D0 (en)	2002-07-10	Personal care compositions
ATE489069T1 (de)	2010-12-15	Mundpflegezusammensetzungen und -verfahren
DK1849468T3 (da)	2013-02-04	Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
NO20030156L (no)	2003-03-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK1482967T3 (da)	2013-08-26	Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
GB2384705B (en)	2006-09-27	Cosmetic and related compositions
DK1680134T3 (da)	2014-07-14	Sammensætninger og anvendelser deraf
AU2003258772A8 (en)	2003-12-02	Novel neutracetical and pharmaceutical compositions and their uses
NO20044090L (no)	2004-11-04	Substituert 3-fenyl-5-alkoksy-1,3,4-oksadiazol-24neJr, fremstilling derav og anvendelse i medikamenter